Register Log-in Investor Type


Biosimilar is a name for a biological medicine (one where the active substance – the key ingredient – is an organic compound) which is highly similar to another already approved biological medicine. These biosimilars need to go through the same approval process as the original medicine. They differ from generics in that they are not exact copies of the original compound.

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…